Healthcare - Biotechnology - NASDAQ - US
$ 9.84
-1.85 %
$ 833 M
Market Cap
-6.35
P/E
BALANCE SHEET
118 M
ASSETS
71 M
LIABILITIES
47.3 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Liquidia Corporation
| Current Assets | 89.9 M |
| Cash & Short-Term Investments | 83.7 M |
| Receivables | 4.06 M |
| Other Current Assets | 2.16 M |
| Non-Current Assets | 28.4 M |
| Long-Term Investments | 0 |
| PP&E | 6.18 M |
| Other Non-Current Assets | 22.2 M |
| Current Liabilities | 18.6 M |
| Accounts Payable | 1.4 M |
| Short-Term Debt | 2.28 M |
| Other Current Liabilities | 14.9 M |
| Non-Current Liabilities | 52.5 M |
| Long-Term Debt | 2.36 M |
| Other Non-Current Liabilities | 50.1 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Cash & Cash Equivalents | 83.7 | 93.3 | 57.5 | 65.3 | 55.8 | 39.5 | 3.4 | 1.4 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.1 | 5.0 | 3.0 | 0 | 0 | 0.3 | 1.6 | 1.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Other Current Assets | 2.2 | 1.5 | 0.8 | 0.8 | 0.6 | 0.2 | 0.1 | 0.5 |
| Total Current Assets | 89.9 | 99.8 | 61.3 | 66.1 | 56.4 | 40.0 | 5.5 | 3.1 |
| PP&E | 6.2 | 6.3 | 7.4 | 9.5 | 12.1 | 8.1 | 8.2 | 4.3 |
| Intangible Assets | 3.4 | 3.7 | 4.4 | 5.5 | 0 | 0 | 0 | 0 |
| Goodwill | 3.9 | 3.9 | 3.9 | 3.9 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | (2.1) | (2.5) | (1.5) | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 14.9 | 15.5 | 16.7 | 14.6 | 0.4 | 1.3 | 1.1 | 1.0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 118.3 | 129.2 | 93.7 | 99.5 | 68.8 | 49.4 | 14.8 | 8.5 |
| LIABILITIES | ||||||||
| Accounts Payable | 1.4 | 2.2 | 1.1 | 3.7 | 3.5 | 3.2 | 4.4 | 2.4 |
| Short Term Debt | 2.3 | 2.2 | 1.1 | 1.6 | 7.4 | 0.8 | 16.1 | 3.2 |
| Other Current Liabilities | 14.9 | 4.4 | 5.2 | 6.4 | 6.0 | 4.2 | 6.4 | 3.1 |
| Total Current Liabilities | 18.6 | 8.8 | 7.3 | 11.7 | 16.9 | 8.2 | 30.5 | 12.1 |
| Long Term Debt | 2.4 | 23.4 | 14 993 379.6 | 15.6 | 17.0 | 12.0 | 6.1 | 5.5 |
| Deferred Tax Income | 0 | 2.1 | 2.5 | 1.5 | 0 | (0.4) | (0.5) | (0.2) |
| Other Liabilities | 50.1 | 6.6 | (14 993 358.4) | 1.2 | 0 | 2.4 | 6.4 | 0.5 |
| Total Liabilities | 71.0 | 38.8 | 28.5 | 28.4 | 33.9 | 30.7 | 48.5 | 26.7 |
| EQUITY | ||||||||
| Common Stock | 69 K | 64 K | 52.3 K | 43.3 K | 28.2 K | 15.5 K | 570 | 554 |
| Retained Earnings | (429.1) | (350.6) | (309.6) | (275.0) | (215.2) | (167.1) | (113.4) | (84.3) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 0 | 0 | 0 | (9.3) | (7.8) | (6.9) |
| Total Equity | 47.3 | (350.6) | (309.6) | (275.0) | 34.9 | 18.7 | (33.7) | (18.2) |
| Total Liabilities and Equity | 118.3 | (311.8) | (281.1) | (246.6) | 68.8 | 49.4 | 14.8 | 8.5 |
| SHARES OUTSTANDING | ||||||||
| Common Shares Outstanding | 65.0 | 61.0 | 49.7 | 33.9 | 18.5 | 7.2 | 8.6 | 5.1 |